Tygh Capital Management, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$3,409,000
-0.5%
84,782
+0.6%
0.44%
-6.0%
Q3 2021$3,427,000
+0.9%
84,244
+12.6%
0.46%
+0.2%
Q2 2021$3,398,000
+7.8%
74,825
-1.0%
0.46%
+4.0%
Q1 2021$3,151,000
+1.5%
75,573
+4.0%
0.44%
-7.9%
Q4 2020$3,103,000
+63.3%
72,660
+0.5%
0.48%
+34.2%
Q3 2020$1,900,00072,3040.36%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders